Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bioadaptives (BDPT) Short-term Investments (2019 - 2023)

Bioadaptives' Short-term Investments history spans 5 years, with the latest figure at $11.0 for Q3 2023.

  • Quarterly results put Short-term Investments at $11.0 for Q3 2023, down 65.62% from a year ago — trailing twelve months through Sep 2023 was $11.0 (down 65.62% YoY), and the annual figure for FY2022 was $42.0, down 77.89%.
  • Short-term Investments for Q3 2023 was $11.0 at Bioadaptives, down from $21.0 in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $3278.0 in Q1 2021 to a low of $11.0 in Q3 2023.
  • The 5-year median for Short-term Investments is $264.0 (2021), against an average of $556.83.
  • The sharpest move saw Short-term Investments tumbled 96.3% in 2020, then soared 1107.94% in 2021.
  • Year by year, Short-term Investments stood at $772.0 in 2019, then tumbled by 42.49% to $444.0 in 2020, then plummeted by 57.21% to $190.0 in 2021, then plummeted by 77.89% to $42.0 in 2022, then crashed by 73.81% to $11.0 in 2023.
  • According to Business Quant data, Short-term Investments over the past three periods came in at $11.0, $21.0, and $32.0 for Q3 2023, Q2 2023, and Q1 2023 respectively.